Editing Beta blocker (section)

==== Asthma ====
The 2007 National Heart, Lung, and Blood Institute ([[NHLBI]]) asthma guidelines recommend against the use of non-selective beta blockers in asthmatics, while allowing for the use of cardio selective beta blockers.<ref name="NHLBI Asthma 07">{{cite journal | vauthors = ((National Heart, Lung, and Blood Institute)) | author-link = National Heart, Lung, and Blood Institute | title = Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007 | journal = [[The Journal of Allergy and Clinical Immunology]] | volume = 120 | issue = 5 | pages = S94–S138 | year = 2007 | url = https://www.jacionline.org/article/S0091-6749(07)01823-4/fulltext | doi = 10.1016/j.jaci.2007.09.029 | access-date = 2017-12-09 | archive-url = https://web.archive.org/web/20210828002833/https://www.jacionline.org/article/S0091-6749%2807%2901823-4/fulltext | doi-access = free | archive-date = August 28, 2021 }}</ref>{{rp|182}}

Cardio selective beta blocker (β<sub>1</sub> blockers) can be prescribed at the least possible dose to those with mild to moderate respiratory symptoms.<ref name="Morales Jackson Lipworth Donnan 2014 pp. 779–786"/><ref name="Salpeter Ormiston Salpeter p=715">{{cite journal | vauthors = Salpeter SR, Ormiston TM, Salpeter EE | title = Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis | journal = Annals of Internal Medicine | volume = 137 | issue = 9 | pages = 715–725 | date = November 2002 | pmid = 12416945 | doi = 10.7326/0003-4819-137-9-200211050-00035 | publisher = American College of Physicians | doi-access = free }}</ref> [[β2-agonist]]s can somewhat mitigate β-blocker-induced [[bronchospasm]] where it exerts greater efficacy on reversing ''selective'' β-blocker-induced bronchospasm than the ''nonselective'' β-blocker-induced worsening asthma and/or COPD.<ref name="Morales Jackson Lipworth Donnan 2014 pp. 779–786">{{cite journal | vauthors = Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B | title = Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials | journal = Chest | volume = 145 | issue = 4 | pages = 779–786 | date = April 2014 | pmid = 24202435 | doi = 10.1378/chest.13-1235 | publisher = Elsevier BV }}</ref>